Collectively, these findings establish that aligning molecular targeting (NF-κB-LCN2 modulation) with the pathophysiological context via ROS-gated delivery provides a synergistic strategy for AF repair and attenuation of IVDD progression. Here, LCN2 is linked to atrial fibrillation.